Business

EQT to acquire Europa Biosite, a distributor of life science products

EQT Healthcare Growth ("EQT") has agreed to acquire a majority stake in Europa Biosite (or "the Company") - a distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances used in healthcare R&D - from Adelis Equity. Headquartered in Stockholm, the Company operates in 17 countries across Europe and North America and supports more than 60,000 researchers in academia and biopharma.

articleEqt AbJuly 3, 20253/company/eqt-ab/news/eqt-to-acquire-europa-biosite-a-distributor-of-life-science-products
EQT to acquire Europa Biosite, a distributor of life science products

About this update from Eqt Ab

[{"type":"list","items":[{"val":[{"type":"text","content":"EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe and North America, from Adelis Equity        ","length":235,"tagName":"p"}]},{"val":[{"type":"text","content":"EQT will support Europa Biosite's next phase of growth through commercial excellence initiatives, digital upgrades, expanded product access, and continued M&A, with the company set to benefit from continued demand for advanced research tools","length":249,"tagName":"p"}]},{"val":[{"type":"text","content":"The investment builds on EQT's track record in specialised distribution, including Azelis, Beijer Ref, and OEM International","length":128,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":612,"olType":false},{"type":"text","content":"STOCKHOLM, July 3, 2025 /PRNewswire/ -- EQT Healthcare Growth ("EQT") has agreed to acquire a majority stake in Europa Biosite (or "the Company") - a distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances used in healthcare R&D - from Adelis Equity. Headquartered in Stockholm, the Company operates in 17 countries across Europe and North America and supports more than 60,000 researchers in academia and biopharma.","length":501,"tagName":"p"},{"type":"text","content":"Europa Biosite offers access to over ten million individual scientific products essential to life sciences research, such as antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens, from a wide range of science-led suppliers. It has grown to become a partner for both suppliers and scientists, building on its highly localized footprint and strong technical sales capabilities. The Company serves a fragmented and fast-moving industry, which is expected to benefit from stable research funding.","length":516,"tagName":"p"},{"type":"text","content":"EQT Healthcare Growth seeks to scale healthcare companies by building commercial muscle and expanding reach, building on EQT's three-decade track record in the healthcare sector. Europa Biosite will draw on this experience to expand its own-brand offering in biospecimens, continue its acquisition strategy to strengthen local market pres...

More updates from Eqt Ab

Europa BiositeEQT Healthcare Growthlife sciencethe companyBeijer RefAdelis Equity